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Abstract
The objective of this project is to test for possible correlation between the trend of 
Tuberculosis incidence rate in the US and the Tuberculosis incidence rate in Puerto
Rico from 1993 to 2017. Data from CDC Wonder- Online Tuberculosis Information
System and Pearson Correlation test were used to investigate the relationship. 
Analysis shows a positive association and a significant correlation between TB 
incidence rate between both region during the 26-year timeframe. This result has the 
potential for in-depth future research to identify the common variables and causes for 
the positive correlation. 




• Airborne aerosol (Highly 
infectious)2.
• Effect kidney, spine and 
other major organs2. 
Source: health.Harvard.edu13 
Background 
• Tuberculosis is one of the top leading cause of death in the world3.
• In 2018, estimated 10 million new cases of TB was recorded with about 1.5 million
deaths3.
• Why is TB so prevalent: difficulty in diagnosing, lack of medical infrastructure, low 
vaccine access, low reportings, increase in HIV/immunosuppressed cases and drug 
resistance4,5,6.
• World’s tuberculosis incidence rate is reducing at 1.5%; 
• WHO’s goal of 5% reduction in 2020 and 10% in 20257.
• In 2017, US had reported around 2.8 new cases of TB per 100,0009 
• Puerto Rico had even lower incidence rates of about 1.5 TB cases per 100,0008. 
Research focus: 
• Identify candidate countries with steady decrease in TB incidence rate over 25 
years (1993-2017) 
Hypothesis:
• There is a significant, positive correlation between Tuberculosis incidence rate 
trend in US and the Tuberculosis incidence-rate trend in Puerto Rico from 1993 to 
2017.  
Year US Rate per 100,000 PR Rate per 100,000 
2017 2.8 1.2 
2016 2.86 2.03 
2015 2.97 1.5 
2014 2.95 1.24 
2013 3.02 1.36 
2012 3.16 1.95 
2011 3.37 1.36 
2010 3.59 2.15 
2009 3.75 1.68 
2008 4.24 2.53 
2007 4.41 2.59 
2006 4.6 2.94 
2005 4.76 2.96 
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** Correlat ion is s ignificant at t he 0.01 level (2 -ta i led). 
Trend between US and PR 
Figure 1: Graph of the Tuberculosis Incidence rate (per 100,000) between 1993 and 
2017. A steady and constant decline is seen for both the US and Puerto Rico. 
Methods 
Data Collection: CDC wonder database 
• “Online Tuberculosis Information System” was used to select TB-incidence rate 
data from year 1993 to 2017 for US and PR. 
Data Analysis: Pearson Correlation test (Sample size, n=26)
• The dependent variable: TB incidence rate per 100,000 in US, and TB incidence 
rate per 100,000 in Puerto Rico. 
• The independent variable: Timeline from 1993 to 2017.
Conclusion 
• There is a strong, positive and significant correlation between the TB incidence rate 
of US and Puerto Rico from 1993 to 2017. 
Future Direction 
• Identify possible causes for the decline in TB incidence rate 
• Public Health policies, socio-economic development, fighting risk
factors, better medical education, Infection control, and improvement 
in diagnosis/TB Therapy could have caused the decline is TB 
incidence rate11,12.
• Cross-reference both regions for same/similar healthcare efforts that have enabled 
decreased TB spread
• Apply these programs globally to combat the spread of Tuberculosis 
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